StockNews.com downgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research note published on Saturday. A number of other research firms have also recently issued reports on DXCM. Raymond James boosted their target price on DexCom from $151.00 to $160.00 and gave the company a strong-buy […]